MSB vs RGT

ASX Healthcare sector comparison — updated 22 Jul 2026 — Healthcare sector

MSB

MESOBLAST FPO [MSB]

41LOW

RGT

ARGENTBIO FPO [RGT]

44LOW

Score Breakdown

MSB RGT
Technical
35
51
Catalyst
53
51
Sentiment
50
50
Fundamental
80
34
Momentum
60
50
Risk Gate
40
37

Key Metrics

MSB Metric RGT
$3.1BMarket Cap$5.8M
4.1MAvg Volume (20d)1.2M
+7.8%Short InterestN/A
$3.31052-Week High$0.320
$1.88052-Week Low$0.033
-4.5%Daily Change+8.0%
$2.320Reference Price$0.054
-18.2%ROEN/A
-144.3%Profit MarginN/A

Active Signals

MSB Signals

●Above-average volume (1.6x) on a red day — sellers in control
●Took a hit — down 10.4% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (9 quarters)
●Strong revenue growth (+1527%)
●EPS estimates revised upward (+10pts)
●Director buying detected (1 transactions)
●Elevated short interest (7.8%)

RGT Signals

●MACD momentum is losing steam
●Stochastic just turned bullish from a low level — early reversal sign
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Took a hit — down 11.5% over the last 5 days
●Beating the Small Ords index — relative strength of 1.53, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (0.8 quarters)
●Strong revenue growth (+3905%)

Ask Scout AI to compare MSB and RGT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

MSB vs RHY →MSB vs SNT →MSB vs TRU →MSB vs TTX →MSB vs VBS →
MSB Full Analysis → RGT Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).